ScholarIQanswers from OpenAlex

Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines

PaperCitations, authors & open-access status

Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines have?

ScholarIQcitation count

Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines has 31 citations in the OpenAlex counts ScholarIQ stores.

When was Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines published?

ScholarIQyear

Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines has 2022 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines?

ScholarIQoa status

Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines has gold oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines?

ScholarIQdoi

The DOI for Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines is on the source record.

Open the DOI →

What is the OpenAlex record for Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines?

ScholarIQopenalex

The OpenAlex for Extension of Interval-Valued Fermatean Fuzzy TOPSIS for Evaluating and Benchmarking COVID-19 Vaccines is on the source record.

Open the OpenAlex →